Clinical Trial Update: Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interleukin-2 with or without histamine dihydrochloride for metastatic renal cell carcinoma (kidney cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Aldesleukin (Proleukin) (aldesleukin)
• Histamine dihydrochloride (histamine dihydrochloride)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN